228 related articles for article (PubMed ID: 30245630)
1.
César-Razquin A; Girardi E; Yang M; Brehme M; Saez-Rodriguez J; Superti-Furga G
Front Pharmacol; 2018; 9():1011. PubMed ID: 30245630
[TBL] [Abstract][Full Text] [Related]
2. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
3. The Role of Transporters in Future Chemotherapy.
Huttunen J; Huttunen KM
Chimia (Aarau); 2022 May; 76(5):454-459. PubMed ID: 38069717
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
Özvegy-Laczka C; Ungvári O; Bakos É
Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
[TBL] [Abstract][Full Text] [Related]
5. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
Döring B; Petzinger E
Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
[TBL] [Abstract][Full Text] [Related]
6. Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption.
Al-Ali AAA; Nielsen RB; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2019 Jul; 566():410-433. PubMed ID: 31125713
[TBL] [Abstract][Full Text] [Related]
7. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
8. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
9. The solute carrier transporters and the brain: Physiological and pharmacological implications.
Hu C; Tao L; Cao X; Chen L
Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195
[TBL] [Abstract][Full Text] [Related]
10. The Important Role of Transporter Structures in Drug Disposition, Efficacy, and Toxicity.
Fu T; Zeng S; Zheng Q; Zhu F
Drug Metab Dispos; 2023 Oct; 51(10):1316-1323. PubMed ID: 37295948
[TBL] [Abstract][Full Text] [Related]
11. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
13. An integrative in silico system for predicting dysregulated genes in the human epileptic focus: Application to SLC transporters.
Mirza N; Vasieva O; Appleton R; Burn S; Carr D; Crooks D; du Plessis D; Duncan R; Farah JO; Josan V; Miyajima F; Mohanraj R; Shukralla A; Sills GJ; Marson AG; Pirmohamed M
Epilepsia; 2016 Sep; 57(9):1467-74. PubMed ID: 27421837
[TBL] [Abstract][Full Text] [Related]
14. Role of solute carriers in response to anticancer drugs.
Li Q; Shu Y
Mol Cell Ther; 2014; 2():15. PubMed ID: 26056583
[TBL] [Abstract][Full Text] [Related]
15. Transporters in human platelets: physiologic function and impact for pharmacotherapy.
Jedlitschky G; Greinacher A; Kroemer HK
Blood; 2012 Apr; 119(15):3394-402. PubMed ID: 22337717
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Poveda JL; Montesinos P
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456712
[TBL] [Abstract][Full Text] [Related]
17. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
19. Circadian regulation of transporter expression and implications for drug disposition.
Pácha J; Balounová K; Soták M
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
[No Abstract] [Full Text] [Related]
20. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
Schinkel AH; Jonker JW
Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
